Thomas Reiser/LinkedIn
Oct 18, 2025, 05:21
Thomas Reiser: ISTH Guidelines and Guidance Committee Invites Public Comments on the Guidance Manuscript
Thomas Reiser, Executive Director of the International Society on Thrombosis and Haemostasis (ISTH), shared on LinkedIn:
“Your expertise is requested!
The International Society on Thrombosis and Haemostasis (ISTH) Guidelines & Guidance Committee invites public comments on the guidance manuscript, “Development of New Antithrombotic Drugs for Children (Part 1): Guidance from the SSC Subcommittee on Pediatrics & Neonatal Thrombosis and Hemostasis and the Pedi-ATLAS Group”
Deadline: Oct. 30″
Register here.
Stay informed with Hemostasis Today.
-
Dec 12, 2025, 23:51Don’t Miss: IACH Post ASH 2025 Roundtable Debate
-
Dec 12, 2025, 23:37C-Reactive Protein and Cardiovascular Risk in the General Population: A European Heart Journal Study by Berkan Kurt et al.
-
Dec 12, 2025, 23:23Alta Schutte and Colleagues at National Hypertension Taskforce: Driving Single-Pill Therapy for Hypertension and More
-
Dec 12, 2025, 22:27Normal Counts, High Risk: Abdul Mannan Breaks Down JAK2 + Splanchnic Vein Thrombosis
-
Dec 12, 2025, 14:478 Posts Not to Miss From the ASH 2025 – Marc Carrier
-
Dec 12, 2025, 10:17Alyssa George on Clinical and Economic Impact of a Eptacog Beta
-
Dec 12, 2025, 09:53Ivan Budnik Awarded AHA Postdoctoral Fellowship! Aiming to Improve DVT Long-term Outcomes
-
Dec 12, 2025, 09:34Giles Platford on Baby Big: Plasma-Derived Drug Against Infant Botulism
-
Dec 12, 2025, 09:22Matteo Foschi Presents The New Expert Guidance on Minor Ischemic Stroke